Circulating dendritic cell precursors in chronic kidney disease: A cross-sectional study

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Paul, Katharina ^a   Kretzschmar, Daniel ^a   Yilmaz, Atilla ^a   Bärthlein, Barbara ^b   Titze, Stephanie ^b   Wolf, Gunter ^a   Busch, Martin ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CELL COUNT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DENDRITIC CELL; DENDRITIC CELL PRECURSOR; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MYELOID DENDRITIC CELL; PLASMACYTOID DENDRITIC CELL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD CELL COUNT; CAUSALITY; COMORBIDITY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DENDRITIC CELLS; FEMALE; GERMANY; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; YOUNG ADULT;

EID: 84889837410     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-274     Document Type: Article

References (34)

1. Macrophages and dendritic cells for treating kidney disease. Cao Q, Zheng D, Wang YP, Harris DCH, Nephron Exp Nephrol 2011 117 47 e52 10.1159/000320595 20814218
2. Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production. Agrawal S, Gollapudi P, Elahimehr R, Pahl MV, Vaziri ND, Nephrol Dial Transplant 2010 25 737 746 10.1093/ndt/gfp580 19903659
3. Renal transplantation reverses functional deficiencies in circulating dendritic cell subsets in chronic renal failure patients. Lim WH, Kireta S, Thomson AW, Russ GR, Coates PTH, Transplantation 2006 81 160 168 10.1097/01.tp.0000188620.72969.56 16436957
4. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Liu YJ, Cell 2001 106 259 262 10.1016/S0092-8674(01)00456-1 11509173 (Pubitemid 32772608)
5. The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cells. Hesselink DA, Betjes MGH, Verkade MA, Athanassopoulos P, Baan CC, Weimar W, Nephrol Dial Tranplant 2005 20 1868 1873 10.1093/ndt/gfh897 (Pubitemid 41222601)
6. Dendritic cells in autoimmune diseases. Maddur MS, Vani J, Dimitrov JD, Balaji KN, Lacroix Desmaszes S, Kaveri SV, Bayry J, Op Arthritis 2010 J3 1 7
7. Enumeration and phenotypic assessment of human plasmacytoid and myeloid dendritic cells in whole blood. Chowdhury F, Johnsons P, Williams AP, Cytometry 2010 77A 328 337 10.1002/cyto.a.20872
8. Dendritic cells, chemokine receptors and autoimmune inflammatory diseases. Cravens PD, Lipsky P, Immunol Cell Biol 2002 80 497 505 10.1046/j.1440-1711.2002.01118.x 12225387
9. Recruitment of circulating dendritic cell precursors into the infarcted myocardium and pro-inflammatory response in acute myocardial infarction. Kretzschmar D, Betge S, Windisch A, Pistulli R, Rohm I, Fritzenwanger M, Schubert K, Theis B, Petersen I, Drobnik S, Mall G, Figulla HR, Yilmaz A, Clin Sci 2012 123 387 398 10.1042/CS20110561 22494099
10. Decrease in circulating myeloid dendritic cell precursors in coronary artery disease. Yilmaz A, Weber J, Cicha I, Stumpf C, Klein M, Raithel D, Daniel WG, Garlichs CD, JACC 2006 48 70 80 10.1016/j.jacc.2006.01.078 16814651 (Pubitemid 43929209)
11. Predictive value of the decrease in circulating dendritic cell precursors in stable coronary artery disease. Yilmaz A, Schaller T, Cicha I, Altendorf R, Stumpf C, Klinghammer L, Ludwig J, Daniel WG, Garlichs CD, Clin Sci 2009 116 353 363 10.1042/CS20080392 18808367
12. Change in cardiovascular risk factors with progression of kidney disease. Fried LF, Katz R, Cushman M, Sarnak M, Shlipak MG, Kuller L, Newman AB, Am J Nephrol 2009 29 334 341 10.1159/000166598 18948687
13. Cardiovascular disease in patients with chronic kidney disease. Wright J, Hutchison A, Vasc Health Risk Manag 2009 5 713 722 19756163
14. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Himmelfarb J, Semin Dial 2009 22 636 643 10.1111/j.1525-139X.2009. 00659.x 20017834
15. Immune mechanisms involved in cardiovascular complications of chronic kidney disease. Stinghen AEM, Bucharles S, Riella M, Pecoits-Filho R, Blood Purif 2010 29 114 120 10.1159/000245636 20093815
16. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Matsushita K, Van Der Velde M, Astor BC, Woodward M, Levey AS, De Jong PE, Coresh J, Gansevoort RT, Chronic Kidney Disease Prognosis Consortium, Lancet 2010 375 9731 2073 2081 20483451
17. Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease. Swaminathan S, Shah SV, Kidney Int 2011 80 453 463 10.1038/ki.2011.178 21697810
18. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Levey AS, De Jong PE, Coresh J, Kidney Int 2011 80 17 28 10.1038/ki.2010.483 21150873
19. Inflammation, atherosclerosis, and coronary artery disease. Hansson G, N Engl J Med 2005 352 1685 1695 10.1056/NEJMra043430 15843671 (Pubitemid 40530235)
20. The German Chronic Kidney Disease (GCKD) study: design and methods. Eckardt KU, Barthlein B, Baid Agrawal S, Beck A, Busch M, Eitner F, Ekici AB, Floege J, Gefeller O, Haller H, Hilge R, Hilgers KF, Kielstein JT, Krane V, Köttgen A, Kronenberg F, Oefner P, Prokosch HU, Reis A, Schmid M, Schaeffner E, Schultheiss UT, Seuchter SA, Sitter T, Sommerer C, Walz G, Wanner C, Wolf G, Zeier M, Titze S, Nephrol Dial Transplant 2011 27 1454 1460 21862458
21. The scope of coronary heart disease in patients with chronic kidney disease. Hage FG, Venkataraman R, Zoghbi GJ, Perry GJ, DeMattos AM, Iskandrian AE, J Am Coll Cardiol 2009 53 2129 2140 10.1016/j.jacc.2009.02.047 19497438
22. Changes in blood dendritic cell counts in relation to type of coronary artery disease and brachial endothelial cell function. Van Vré EA, Brussel I, Beeck KO, Hoymans VY, Vrints C, Bult H, Bosmans JM, Coron Artery Dis 2010 21 87 96 10.1097/MCA.0b013e3283368c0e 20124992
23. Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease. Van Vré EA, Hoymans VY, Bult H, Lenjou M, Van Bockstaele DR, Vrints CJ, Bosmans JM, Coron Artery Dis 2006 17 243 248 10.1097/00019501-200605000-00007 16728874 (Pubitemid 44324834)
24. Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood. Van Brussel I, Van Vré EA, Meyer GRY, Vrints CJ, Bosmans JM, Bult H, J Immunol Methods 2010 362 168 175 10.1016/j.jim.2010.09.031 20888334
25. Peripheral-blood dendritic cells in men with coronary artery disease. Shi H, Ge J, Fang W, Yao K, Sun A, Huang R, Jia Q, Wang K, Zou Y, Cao X, Am J Cardiol 2007 100 4 593 597 10.1016/j.amjcard.2007.03.067 17697812 (Pubitemid 47223132)
26. Uremia impairs monocyte-derived dendritic cell function in hemodialysis patients. Lim WH, Kireta S, Leedham E, Russ GR, Coates PT, Kidney Int 2007 72 9 1138 1148 10.1038/sj.ki.5002425 17728708 (Pubitemid 47609031)
27. Vitamin D status and mortality in chronic kidney disease. Pilz S, Tomaschitz A, Friedl C, Amrein K, Drechsler C, Ritz E, Boehm BO, Grammer TB, März W, Nephrol Dial Transplant 2011 26 3603 3609 10.1093/ndt/gfr076 21378153
28. Toll-like receptor triggering of vitamin D-mediated human antimicrobial response. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL, Science 2006 311 1770 1773 10.1126/science.1123933 16497887
29. Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Takeda M, Yamashita T, Sasaki N, Nakajima K, Kita T, Shinohara M, Ishida T, Hirata K, Arterioscler Thromb Vasc Biol 2010 30 12 2495 2503 10.1161/ATVBAHA.110.215459 20930170
30. Human C-reactive protein activated monocyte-derived dendritic cells and induces dendritic cell-mediated T-cell activation. Van Vré E, Bult H, Hoymans VY, Van Tendeloo VFI, Vrints CJ, Bosmans JM, Arterioscler Thromb Vasc Biol 2007 28 511 518
31. Decreased migration of myeloid dendritic cells through increased levels of C-reactive protein. Frenzel H, Pries R, Brocks CP, Jabs WJ, Wittkopf N, Wollenberg B, Anticancer Res 2007 27 4111 4116 18225580
32. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Boren E, Gershwin ME, Autoimmun Rev 2004 3 5 401 406 10.1016/j.autrev.2004.03.004 15288008 (Pubitemid 38993363)
33. Accelerated autoimmune disease in MRL (MpJ-Fas (lpr) but not in MRL/MpJ following immunization with high load of syngeneic late apoptotic cells. Shoshan Y, Mevorach D, Autoimmunity 2004 37 2 103 109 10.1080/08916930410001666622 15293880 (Pubitemid 38594274)
34. Dendritic cell induce peripheral T cell unresponsiveness under steady state conditions in vivo. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, Ravetch JV, Steinman RM, Nussenzweig MC, J Exp Med 2001 194 6 769 779 10.1084/jem.194.6.769 11560993 (Pubitemid 32983013)